# Sarclisa

NDC: 0024-0656
Generic name: isatuximab
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20200302

FDA application: BLA761113

## Active ingredients

- ISATUXIMAB: 500 mg/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-0656"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-0656
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0473462-6f9d-4eca-a5bf-8620aea68e8a